<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Case Western Reserve University, [3], 0000 0001 2164 3847grid.67105.35Case Comprehensive" exact="Cancer" post="Center, Case Western Reserve University School of Medicine, epub:"/>
 <result pre="this license, visit http://creativecommons.org/licenses/by/4.0/. Abstract Human coronaviruses (HCoVs), including severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV,"/>
 <result pre="license, visit http://creativecommons.org/licenses/by/4.0/. Abstract Human coronaviruses (HCoVs), including severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also"/>
 <result pre="visit http://creativecommons.org/licenses/by/4.0/. Abstract Human coronaviruses (HCoVs), including severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and 2019 novel coronavirus (2019-nCoV, also known"/>
 <result pre="&amp;amp; Human Services | NIH | National Heart, Lung, and" exact="Blood" post="Institute (NHLBI) K99HL138272R00HL138272ChengFeixiong Funding U.S. Department of Health &amp;amp;"/>
 <result pre="&amp;amp; Human Services | NIH | National Heart, Lung, and" exact="Blood" post="Institute (NHLBI) Introduction Coronaviruses (CoVs) typically affect the respiratory"/>
 <result pre="and Blood Institute (NHLBI) Introduction Coronaviruses (CoVs) typically affect the" exact="respiratory" post="tract of mammals, including humans, and lead to mild"/>
 <result pre="of mammals, including humans, and lead to mild to severe" exact="respiratory" post="tract infections1. In the past two decades, two highly"/>
 <result pre="two decades, two highly pathogenic human CoVs (HCoVs), including severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome"/>
 <result pre="decades, two highly pathogenic human CoVs (HCoVs), including severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus"/>
 <result pre="two highly pathogenic human CoVs (HCoVs), including severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV),"/>
 <result pre="including severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV), emerging from animal reservoirs, have led"/>
 <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV), emerging from animal reservoirs, have led to"/>
 <result pre="Organization (WHO), as of November 2019, MERS-CoV has had a" exact="total" post="of 2494 diagnosed cases causing 858 deaths, the majority"/>
 <result pre="named 2019 novel coronavirus (2019-nCoV/SARS-CoV-2), as the cause of coronavirus" exact="disease" post="2019 (abbreviated as COVID-19)5, was found in Wuhan, China."/>
 <result pre="hypotheses for systematic drug repositioning9â€&quot;11,13,14. However, traditional structure-based methods are" exact="limited" post="when three-dimensional (3D) structures of proteins are unavailable, which,"/>
 <result pre="unfortunately, is the case for the majority of human and" exact="viral" post="targets. In addition, targeting single virus proteins often has"/>
 <result pre="(PPIs) offers an effective way toward elucidating the mechanisms of" exact="viral" post="infection15,16. Subsequently, targeting cellular antiviral targets, such as virusâ€&quot;host"/>
 <result pre="a novel strategy for the development of effective treatments for" exact="viral" post="infections1, including SARS-CoV17, MERS-CoV17, Ebola virus18, and Zika virus14,19â€&quot;21."/>
 <result pre="light on the relationship between drugs (e.g., drug targets) and" exact="disease" post="modules (molecular determinants in disease pathobiology modules within the"/>
 <result pre="drugs (e.g., drug targets) and disease modules (molecular determinants in" exact="disease" post="pathobiology modules within the PPIs), and can serve as"/>
 <result pre="the notions that (i) the proteins that functionally associate with" exact="viral infection" post="(including HCoV) are localized in the corresponding subnetwork within"/>
 <result pre="notions that (i) the proteins that functionally associate with viral" exact="infection" post="(including HCoV) are localized in the corresponding subnetwork within"/>
 <result pre="proteins that functionally associate with viral infection (including HCoV) are" exact="localized" post="in the corresponding subnetwork within the comprehensive human PPI"/>
 <result pre="(ii) proteins that serve as drug targets for a specific" exact="disease" post="may also be suitable drug targets for potential antiviral"/>
 <result pre="disease may also be suitable drug targets for potential antiviral" exact="infection" post="owing to common PPIs and functional pathways elucidated by"/>
 <result pre="methodology: (i) the proteins that functionally associate with HCoVs are" exact="localized" post="in the corresponding subnetwork within the comprehensive human interactome"/>
 <result pre="(ii) proteins that serve as drug targets for a specific" exact="disease" post="may also be suitable drug targets for potential antiviral"/>
 <result pre="disease may also be suitable drug targets for potential antiviral" exact="infection" post="owing to common proteinâ€&quot;protein interactions elucidated by the human"/>
 <result pre="have five major protein regions for virus structure assembly and" exact="viral" post="replications29, including replicase complex (ORF1ab), spike (S), envelope (E),"/>
 <result pre="2b). The ORF1ab gene encodes the non-structural proteins (nsp) of" exact="viral" post="RNA synthesis complex through proteolytic processing30. The nsp12 is"/>
 <result pre="RNA synthesis complex through proteolytic processing30. The nsp12 is a" exact="viral" post="RNA-dependent RNA polymerase, together with co-factors nsp7 and nsp8"/>
 <result pre="a transmembrane glycoprotein that plays a pivotal role in mediating" exact="viral infection" post="through binding the host receptor31,32. Figure 2d shows the"/>
 <result pre="transmembrane glycoprotein that plays a pivotal role in mediating viral" exact="infection" post="through binding the host receptor31,32. Figure 2d shows the"/>
 <result pre="the nucleocapsid is also an important subunit for packaging the" exact="viral" post="genome through protein oligomerization35, and the single nucleocapsid structure"/>
 <result pre="and the single nucleocapsid structure is shown in Fig. 2e." exact="Protein" post="sequence alignment analyses indicated that the 2019-nCoV/SARS-CoV-2 was most"/>
 <result pre="Gene ontology (GO) biological process enrichment analysis further confirmed multiple" exact="viral" post="infection-related processes (adjusted P value 3c). We then mapped"/>
 <result pre="notions that the proteins that associate with and functionally govern" exact="viral infection" post="are localized in the corresponding subnetwork (Fig. 1a) within"/>
 <result pre="that the proteins that associate with and functionally govern viral" exact="infection" post="are localized in the corresponding subnetwork (Fig. 1a) within"/>
 <result pre="proteins that associate with and functionally govern viral infection are" exact="localized" post="in the corresponding subnetwork (Fig. 1a) within the comprehensive"/>
 <result pre="Top 16 network-predicted repurposable drugs with literature-derived antiviral evidence. HBV" exact="hepatitis" post="B virus, HCV hepatitis C virus, HDV hepatitis delta"/>
 <result pre="drugs with literature-derived antiviral evidence. HBV hepatitis B virus, HCV" exact="hepatitis C" post="virus, HDV hepatitis delta virus, EBOV Ebola viruses, ZEBOV-GP"/>
 <result pre="evidence. HBV hepatitis B virus, HCV hepatitis C virus, HDV" exact="hepatitis delta" post="virus, EBOV Ebola viruses, ZEBOV-GP Zaire Ebola virus glycoprotein,"/>
 <result pre="EBOV Ebola viruses, ZEBOV-GP Zaire Ebola virus glycoprotein, HIV human" exact="immunodeficiency" post="virus, EBV Epstein-Barr virus, ANDV Andes orthohantavirus, EMCV encephalomyocarditis"/>
 <result pre="Andes orthohantavirus, EMCV encephalomyocarditis virus, FECV feline enteric coronavirus, RSV" exact="respiratory" post="syncytial virus, EV71 enterovirus 71, HSV-1 and -2 herpes"/>
 <result pre="RSV respiratory syncytial virus, EV71 enterovirus 71, HSV-1 and -2" exact="herpes" post="simplex viruses, CVB4 Coxsackievirus B4. Selective estrogen receptor modulators"/>
 <result pre="71, HSV-1 and -2 herpes simplex viruses, CVB4 Coxsackievirus B4." exact="Selective" post="estrogen receptor modulators An overexpression of estrogen receptor has"/>
 <result pre="has been shown to play a crucial role in inhibiting" exact="viral" post="replication37. Selective estrogen receptor modulators (SERMs) have been reported"/>
 <result pre="shown to play a crucial role in inhibiting viral replication37." exact="Selective" post="estrogen receptor modulators (SERMs) have been reported to play"/>
 <result pre="have been reported to play a broader role in inhibiting" exact="viral" post="replication through the non-classical pathways associated with estrogen receptor37."/>
 <result pre="pathways associated with estrogen receptor37. SERMs interfere at the post" exact="viral" post="entry step and affect the triggering of fusion, as"/>
 <result pre="the SERMsâ€™ antiviral activity still can be observed in the" exact="absence of" post="detectable estrogen receptor expression18. Toremifene (Zâ€‰=â€‰â€&quot;3.23, Fig. 5a), the"/>
 <result pre="generation of nonsteroidal SERM, exhibits potential effects in blocking various" exact="viral" post="infections, including MERS-CoV, SARS-CoV, and Ebola virus in established"/>
 <result pre="the classical ESR1-related antiviral pathway, toremifene prevents fusion between the" exact="viral" post="and endosomal membrane by interacting with and destabilizing the"/>
 <result pre="with and destabilizing the virus membrane glycoprotein, and eventually inhibiting" exact="viral" post="replication39. As shown in Fig. 5b, toremifene potentially affects"/>
 <result pre="inhibiting the entry of Zaire Ebola virus glycoprotein and human" exact="immunodeficiency" post="virus (ZEBOV-GP/HIV)18. Altogether, network-predicted SERMs (such as toremifene and"/>
 <result pre="Angiotensin receptor blockers (ARBs) have been reported to associate with" exact="viral infection," post="including HCoVs42â€&quot;44. Irbesartan (Zâ€‰=â€‰â€&quot;5.98), a typical ARB, was approved"/>
 <result pre="typical ARB, was approved by the FDA for treatment of" exact="hypertension" post="and diabetic nephropathy. Here, network proximity analysis shows a"/>
 <result pre="was approved by the FDA for treatment of hypertension and" exact="diabetic nephropathy." post="Here, network proximity analysis shows a significant association between"/>
 <result pre="has been identified as a functional preS1-specific receptor for the" exact="hepatitis" post="B virus (HBV) and the hepatitis delta virus (HDV)."/>
 <result pre="preS1-specific receptor for the hepatitis B virus (HBV) and the" exact="hepatitis delta" post="virus (HDV). Irbesartan can inhibit NTCP, thus inhibiting viral"/>
 <result pre="hepatitis delta virus (HDV). Irbesartan can inhibit NTCP, thus inhibiting" exact="viral" post="entry45,46. SLC10A1 interacts with C11orf74, a potential transcriptional repressor"/>
 <result pre="mammalian target of rapamycin (mTOR), was reported to effectively block" exact="viral" post="protein expression and virion release effectively50. Indeed, the latest"/>
 <result pre="the latest study revealed the clinical application: sirolimus reduced MERS-CoV" exact="infection" post="by over 60%51. Moreover, sirolimus usage in managing patients"/>
 <result pre="60%51. Moreover, sirolimus usage in managing patients with severe H1N1" exact="pneumonia" post="and acute respiratory failure can improve those patientsâ€™ prognosis"/>
 <result pre="sirolimus usage in managing patients with severe H1N1 pneumonia and" exact="acute" post="respiratory failure can improve those patientsâ€™ prognosis significantly50. Mercaptopurine"/>
 <result pre="usage in managing patients with severe H1N1 pneumonia and acute" exact="respiratory" post="failure can improve those patientsâ€™ prognosis significantly50. Mercaptopurine (Zâ€‰=â€‰â€&quot;2.44"/>
 <result pre="antineoplastic agent with immunosuppressant property, has been used to treat" exact="cancer" post="since the 1950s and expanded its application to several"/>
 <result pre="1950s and expanded its application to several auto-immune diseases, including" exact="rheumatoid arthritis," post="systemic lupus erythematosus, and Crohnâ€™s disease52. Mercaptopurine has been"/>
 <result pre="expanded its application to several auto-immune diseases, including rheumatoid arthritis," exact="systemic" post="lupus erythematosus, and Crohnâ€™s disease52. Mercaptopurine has been reported"/>
 <result pre="its application to several auto-immune diseases, including rheumatoid arthritis, systemic" exact="lupus erythematosus," post="and Crohnâ€™s disease52. Mercaptopurine has been reported as a"/>
 <result pre="MERS-CoV by targeting papain-like protease which plays key roles in" exact="viral" post="maturation and antagonism to interferon stimulation53,54. Mechanistically, mercaptopurine potentially"/>
 <result pre="as JUN, PABPC1, NPM1, and NCL40,55 (Fig. 5d). Anti-inflammatory agents" exact="Inflammatory" post="pathways play essential roles in viral infections56,57. As a"/>
 <result pre="(Fig. 5d). Anti-inflammatory agents Inflammatory pathways play essential roles in" exact="viral" post="infections56,57. As a biogenic amine, melatonin (N-acetyl-5-methoxytryptamine) (Zâ€‰=â€‰â€&quot;1.72 and"/>
 <result pre="processes, and offers a potential strategy in the management of" exact="viral" post="infections58,59. Viral infections are often associated with immune-inflammatory injury,"/>
 <result pre="offers a potential strategy in the management of viral infections58,59." exact="Viral" post="infections are often associated with immune-inflammatory injury, in which"/>
 <result pre="a potential strategy in the management of viral infections58,59. Viral" exact="infections" post="are often associated with immune-inflammatory injury, in which the"/>
 <result pre="treatment, even though melatonin cannot eradicate or even curb the" exact="viral" post="replication or transcription61,62. In addition, the application of melatonin"/>
 <result pre="and reduced toxicity, play an important role in treating various" exact="viral" post="infections65. However, our ability to identify and validate effective"/>
 <result pre="However, our ability to identify and validate effective combinations is" exact="limited" post="by a combinatorial explosion, driven by both the large"/>
 <result pre="clinically efficacious drug combinations28. Relying on approved drug combinations for" exact="hypertension" post="and cancer, we found that a drug combination was"/>
 <result pre="Exposureâ€� pattern: the targets of the drugs both hit the" exact="disease" post="module, but target separate neighborhoods (Fig. 6a). Here we"/>
 <result pre="has demonstrated to improve outcomes in patients with severe H1N1" exact="pneumonia" post="and acute respiratory failure50. The mTOR signaling plays an"/>
 <result pre="to improve outcomes in patients with severe H1N1 pneumonia and" exact="acute" post="respiratory failure50. The mTOR signaling plays an essential role"/>
 <result pre="improve outcomes in patients with severe H1N1 pneumonia and acute" exact="respiratory" post="failure50. The mTOR signaling plays an essential role for"/>
 <result pre="is an approved RNA synthesis inhibitor for treatment of various" exact="cancer" post="types. An early study showed that dactinomycin (1â€‰Î¼g/ml) inhibited"/>
 <result pre="among the approved first-generation nonsteroidal SERMs for the treatment of" exact="metastatic" post="breast cancer68. SERMs (including toremifene) inhibited Ebola virus infection18"/>
 <result pre="the approved first-generation nonsteroidal SERMs for the treatment of metastatic" exact="breast" post="cancer68. SERMs (including toremifene) inhibited Ebola virus infection18 by"/>
 <result pre="by targeting papain-like protease53,54. Melatonin was reported in potential antiviral" exact="infection" post="via its anti-inflammatory and antioxidant effects58â€&quot;62. Melatonin indirectly regulates"/>
 <result pre="indirectly regulates ACE2 expression, a key entry receptor involved in" exact="viral infection" post="of HCoVs, including 2019-nCoV/SARS-CoV-2 (ref. 33). Specifically, melatonin was"/>
 <result pre="regulates ACE2 expression, a key entry receptor involved in viral" exact="infection" post="of HCoVs, including 2019-nCoV/SARS-CoV-2 (ref. 33). Specifically, melatonin was"/>
 <result pre="with ACE2 by inhibiting shedding of its ectodomain, a key" exact="infectious" post="process of SARS-CoV72,73. JUN, also known as c-Jun, is"/>
 <result pre="as c-Jun, is a key host protein involving in HCoV" exact="infectious" post="bronchitis virus74. As shown in Fig. 6d, mercaptopurine and"/>
 <result pre="c-Jun, is a key host protein involving in HCoV infectious" exact="bronchitis" post="virus74. As shown in Fig. 6d, mercaptopurine and melatonin"/>
 <result pre="networks from publicly available databases, the network data may be" exact="incomplete" post="and some drugâ€&quot;target interactions may be functional associations, instead"/>
 <result pre="proposed network-based methodologies further. Owing to a lack of the" exact="complete" post="drug-target information (such as the molecular â€œpromiscuityâ€� of drugs),"/>
 <result pre="current network models. For example, Mesalazine, an approved drug for" exact="inflammatory bowel disease," post="is a top network-predicted repurposable drug associated with HCoVs"/>
 <result pre="network models. For example, Mesalazine, an approved drug for inflammatory" exact="bowel" post="disease, is a top network-predicted repurposable drug associated with"/>
 <result pre="HCoVs (Fig. 5a). Yet, several clinical studies showed the potential" exact="pulmonary" post="toxicities (including pneumonia) associated with mesalazine usage81,82. Integration of"/>
 <result pre="efficiency and side effects before clinical trials. Furthermore, we only" exact="limited" post="to predict pairwise drug combinations based on our previous"/>
 <result pre="here could help develop effective treatment strategies for other emerging" exact="viral" post="infections and other human complex diseases as well. Methods"/>
 <result pre="could help develop effective treatment strategies for other emerging viral" exact="infections" post="and other human complex diseases as well. Methods and"/>
 <result pre="Whole-genome alignment and protein sequence identity calculation were performed by" exact="Multiple" post="Sequence Alignment in EMBL-EBI database (https://www.ebi.ac.uk/) with default parameters."/>
 <result pre="HCoV proteins or were involved in critical pathways of HCoV" exact="infection" post="identified by multiple experimental sources, including high-throughput yeast-two-hybrid (Y2H)"/>
 <result pre="identified by multiple experimental sources, including high-throughput yeast-two-hybrid (Y2H) systems," exact="viral" post="protein pull-down assay, in vitro co-immunoprecipitation and RNA knock"/>
 <result pre="comprehensive list of human PPIs, we assembled data from a" exact="total" post="of 18 bioinformatics and systems biology databases with five"/>
 <result pre="effective only if it follows a specific relationship to the" exact="disease" post="module, as captured by Complementary Exposure patterns in targetsâ€™"/>
 <result pre="them, two transcriptome data sets were SARS-CoV-infected samples from patientâ€™s" exact="peripheral" post="blood94 (GSE1739) and Calu-3 cells95 (GSE33267), respectively. One transcriptome"/>
 <result pre="This work was supported by the National Heart, Lung, and" exact="Blood" post="Institute of the National Institutes of Health (NIH) under"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet202039550751310.1016/S0140-6736(20)30211-732007143 6.Li, Q. et"/>
 <result pre="al.Repurposing of clinically developed drugs for treatment of Middle East" exact="respiratory" post="syndrome coronavirus infectionAntimicrob. Agents Chemother.2014584885489310.1128/AAC.03036-1424841273 18.JohansenLMet al.FDA-approved selective estrogen"/>
 <result pre="of clinically developed drugs for treatment of Middle East respiratory" exact="syndrome" post="coronavirus infectionAntimicrob. Agents Chemother.2014584885489310.1128/AAC.03036-1424841273 18.JohansenLMet al.FDA-approved selective estrogen receptor"/>
 <result pre="of the antihistamine chlorcyclizine and related compounds for treatment of" exact="hepatitis C" post="virus infectionSci. Transl. Med.20157282ra24910.1126/scitranslmed.3010286 20.BarrowsNJet al.A screen of FDA-approved"/>
 <result pre="infectionCell Host. Microbe20162025927010.1016/j.chom.2016.07.00427476412 21.XuMet al.Identification of small-molecule inhibitors of Zika" exact="virus infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="Host. Microbe20162025927010.1016/j.chom.2016.07.00427476412 21.XuMet al.Identification of small-molecule inhibitors of Zika virus" exact="infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="novel coronavirus: implications for virus origins and receptor bindingLancet202039556557410.1016/S0140-6736(20)30251-832007145 33.ZhouPengYangXing-LouWangXian-GuangHuBenZhangLeiZhangWeiSiHao-RuiZhuYanLiBeiHuangChao-LinChenHui-DongChenJingLuoYunGuoHuaJiangRen-DiLiuMei-QinChenYingShenXu-RuiWangXiZhengXiao-ShuangZhaoKaiChenQuan-JiaoDengFeiLiuLin-LinYanBingZhanFa-XianWangYan-YiXiaoGeng-FuShiZheng-LiA" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 39.ZhaoYet"/>
 <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell cultureAntimicrob. Agents Chemother.2014584875488410.1128/AAC.03011-1424841269 39.ZhaoYet al.Toremifene"/>
 <result pre="Ebola virus glycoproteinNature201653516917210.1038/nature1861527362232 40.EmmottEet al.The cellular interactome of the coronavirus" exact="infectious" post="bronchitis virus nucleocapsid protein and functional implications for virus"/>
 <result pre="virus glycoproteinNature201653516917210.1038/nature1861527362232 40.EmmottEet al.The cellular interactome of the coronavirus infectious" exact="bronchitis" post="virus nucleocapsid protein and functional implications for virus biologyJ."/>
 <result pre="angiotensin II receptor blocker olmesartan on the development of murine" exact="acute" post="myocarditis caused by coxsackievirus B3Clin. Sci.200611037938610.1042/CS2005029916336207 44.ErlandsonKMet al.The impact"/>
 <result pre="II receptor blocker olmesartan on the development of murine acute" exact="myocarditis" post="caused by coxsackievirus B3Clin. Sci.200611037938610.1042/CS2005029916336207 44.ErlandsonKMet al.The impact of"/>
 <result pre="receptor blocker therapy on cognitive function in adults with human" exact="immunodeficiency" post="virus infectionClin. Infect. Dis.2017652042204910.1093/cid/cix64529020174 45.WangXJet al.Irbesartan, an FDA approved"/>
 <result pre="infectionClin. Infect. Dis.2017652042204910.1093/cid/cix64529020174 45.WangXJet al.Irbesartan, an FDA approved drug for" exact="hypertension" post="and diabetic nephropathy, is a potent inhibitor for hepatitis"/>
 <result pre="Dis.2017652042204910.1093/cid/cix64529020174 45.WangXJet al.Irbesartan, an FDA approved drug for hypertension and" exact="diabetic nephropathy," post="is a potent inhibitor for hepatitis B virus entry"/>
 <result pre="for hypertension and diabetic nephropathy, is a potent inhibitor for" exact="hepatitis" post="B virus entry by disturbing Na(+)-dependent taurocholate cotransporting polypeptide"/>
 <result pre="sirolimus, and steroids improves outcomes in patients with severe H1N1" exact="pneumonia" post="and acute respiratory failureCrit. Care Med.20144231332110.1097/CCM.0b013e3182a2727d24105455 51.DyallJet al.Middle East"/>
 <result pre="steroids improves outcomes in patients with severe H1N1 pneumonia and" exact="acute" post="respiratory failureCrit. Care Med.20144231332110.1097/CCM.0b013e3182a2727d24105455 51.DyallJet al.Middle East respiratory syndrome"/>
 <result pre="improves outcomes in patients with severe H1N1 pneumonia and acute" exact="respiratory" post="failureCrit. Care Med.20144231332110.1097/CCM.0b013e3182a2727d24105455 51.DyallJet al.Middle East respiratory syndrome and"/>
 <result pre="pneumonia and acute respiratory failureCrit. Care Med.20144231332110.1097/CCM.0b013e3182a2727d24105455 51.DyallJet al.Middle East" exact="respiratory" post="syndrome and severe acute respiratory syndrome: current therapeutic options"/>
 <result pre="and acute respiratory failureCrit. Care Med.20144231332110.1097/CCM.0b013e3182a2727d24105455 51.DyallJet al.Middle East respiratory" exact="syndrome" post="and severe acute respiratory syndrome: current therapeutic options and"/>
 <result pre="failureCrit. Care Med.20144231332110.1097/CCM.0b013e3182a2727d24105455 51.DyallJet al.Middle East respiratory syndrome and severe" exact="acute" post="respiratory syndrome: current therapeutic options and potential targets for"/>
 <result pre="Care Med.20144231332110.1097/CCM.0b013e3182a2727d24105455 51.DyallJet al.Middle East respiratory syndrome and severe acute" exact="respiratory" post="syndrome: current therapeutic options and potential targets for novel"/>
 <result pre="to therapy-related cancerNat. Rev. Cancer20088243610.1038/nrc229218097462 53.ChenXChouCYChangGGThiopurine analogue inhibitors of severe" exact="acute" post="respiratory syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzymeAntivir."/>
 <result pre="therapy-related cancerNat. Rev. Cancer20088243610.1038/nrc229218097462 53.ChenXChouCYChangGGThiopurine analogue inhibitors of severe acute" exact="respiratory" post="syndrome-coronavirus papain-like protease, a deubiquitinating and deISGylating enzymeAntivir. Chem."/>
 <result pre="mycophenolic acid synergistically inhibit the papain-like protease of Middle East" exact="respiratory" post="syndrome coronavirusAntivir. Res.201511591610.1016/j.antiviral.2014.12.01125542975 55.ChenHWurmTBrittonPBrooksGHiscoxJAInteraction of the coronavirus nucleoprotein with"/>
 <result pre="acid synergistically inhibit the papain-like protease of Middle East respiratory" exact="syndrome" post="coronavirusAntivir. Res.201511591610.1016/j.antiviral.2014.12.01125542975 55.ChenHWurmTBrittonPBrooksGHiscoxJAInteraction of the coronavirus nucleoprotein with nucleolar"/>
 <result pre="inflammation and anti-inflammatory/analgesic drugsInflammopharmacology2006142910.1007/s10787-006-0002-516835706 57.GarciaCCGuabirabaRSorianiFMTeixeiraMMThe development of anti-inflammatory drugs for" exact="infectious" post="diseasesDiscov. Med.20101047948821189219 58.SilvestriMRossiGAMelatonin: its possible role in the management"/>
 <result pre="diseasesDiscov. Med.20101047948821189219 58.SilvestriMRossiGAMelatonin: its possible role in the management of" exact="viral" post="infections-a brief reviewItal. J. Pediatr.2013396110.1186/1824-7288-39-6124090288 59.SrinivasanVMohamedMKatoHMelatonin in bacterial and"/>
 <result pre="management of viral infections-a brief reviewItal. J. Pediatr.2013396110.1186/1824-7288-39-6124090288 59.SrinivasanVMohamedMKatoHMelatonin in" exact="bacterial" post="and viral infections with focus on sepsis: a reviewRecent"/>
 <result pre="viral infections-a brief reviewItal. J. Pediatr.2013396110.1186/1824-7288-39-6124090288 59.SrinivasanVMohamedMKatoHMelatonin in bacterial and" exact="viral" post="infections with focus on sepsis: a reviewRecent Pat. Endocr."/>
 <result pre="infections-a brief reviewItal. J. Pediatr.2013396110.1186/1824-7288-39-6124090288 59.SrinivasanVMohamedMKatoHMelatonin in bacterial and viral" exact="infections" post="with focus on sepsis: a reviewRecent Pat. Endocr. Metab."/>
 <result pre="AFMK and AMKJ. Pineal Res.20135424525710.1111/jpi.1201022998574 63.XiaoJShimadaMLiuWHuDMatsumoriAAnti-inflammatory effects of eplerenone on" exact="viral" post="myocarditisEur. J. Heart Fail.20091134935310.1093/eurjhf/hfp02319213804 64.WangManliCaoRuiyuanZhangLeikeYangXinglouLiuJiaXuMingyueShiZhengliHuZhihongZhongWuXiaoGengfuRemdesivir and chloroquine effectively inhibit"/>
 <result pre="Pineal Res.20135424525710.1111/jpi.1201022998574 63.XiaoJShimadaMLiuWHuDMatsumoriAAnti-inflammatory effects of eplerenone on viral myocarditisEur. J." exact="Heart" post="Fail.20091134935310.1093/eurjhf/hfp02319213804 64.WangManliCaoRuiyuanZhangLeikeYangXinglouLiuJiaXuMingyueShiZhengliHuZhihongZhongWuXiaoGengfuRemdesivir and chloroquine effectively inhibit the recently emerged"/>
 <result pre="potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East" exact="respiratory" post="syndrome coronavirus infection as identified by temporal kinome analysisAntimicrob."/>
 <result pre="of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory" exact="syndrome" post="coronavirus infection as identified by temporal kinome analysisAntimicrob. Agents"/>
 <result pre="and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus" exact="infection" post="as identified by temporal kinome analysisAntimicrob. Agents Chemother.2015591088109910.1128/AAC.03659-1425487801 67.LewisELHarbourDABeringerJEGrinstedJDifferential"/>
 <result pre="67.LewisELHarbourDABeringerJEGrinstedJDifferential in vitro inhibition of feline enteric coronavirus and feline" exact="infectious" post="peritonitis virus by actinomycin DJ. Gen. Virol.1992733285328810.1099/0022-1317-73-12-32851335030 68.ZhouWBDingQChenLLiuXAWangSToremifene is"/>
 <result pre="in vitro inhibition of feline enteric coronavirus and feline infectious" exact="peritonitis" post="virus by actinomycin DJ. Gen. Virol.1992733285328810.1099/0022-1317-73-12-32851335030 68.ZhouWBDingQChenLLiuXAWangSToremifene is an"/>
 <result pre="and safe alternative to tamoxifen in adjuvant endocrine therapy for" exact="breast" post="cancer: results of four randomized trialsBreast Cancer Res. Treat.201112862563110.1007/s10549-011-1556-521553116"/>
 <result pre="endocrine therapy for breast cancer: results of four randomized trialsBreast" exact="Cancer" post="Res. Treat.201112862563110.1007/s10549-011-1556-521553116 69.CongYet al.MERS-CoV pathogenesis and antiviral efficacy of"/>
 <result pre="of intracellular calcium and calmodulin by melatonin in MCF-7 human" exact="breast cancer" post="cellsJ. Pineal Res.20023211211910.1034/j.1600-079x.2002.1844.x12071468 74.FungTSLiuDXActivation of the c-Jun NH2-terminal kinase"/>
 <result pre="intracellular calcium and calmodulin by melatonin in MCF-7 human breast" exact="cancer" post="cellsJ. Pineal Res.20023211211910.1034/j.1600-079x.2002.1844.x12071468 74.FungTSLiuDXActivation of the c-Jun NH2-terminal kinase"/>
 <result pre="Res.20023211211910.1034/j.1600-079x.2002.1844.x12071468 74.FungTSLiuDXActivation of the c-Jun NH2-terminal kinase pathway by coronavirus" exact="infectious" post="bronchitis virus promotes apoptosis independently of c-JunCell Death Dis.20178321510.1038/s41419-017-0053-029238080"/>
 <result pre="74.FungTSLiuDXActivation of the c-Jun NH2-terminal kinase pathway by coronavirus infectious" exact="bronchitis" post="virus promotes apoptosis independently of c-JunCell Death Dis.20178321510.1038/s41419-017-0053-029238080 75.BiedenkopfNet"/>
 <result pre="drug designNaunyn Schmiedebergs Arch. Pharmacol.201638969571210.1007/s00210-016-1252-427146293 79.LiQet al.Integrative functional genomics of" exact="hepatitis C" post="virus infection identifies host dependencies in complete viral replication"/>
 <result pre="Schmiedebergs Arch. Pharmacol.201638969571210.1007/s00210-016-1252-427146293 79.LiQet al.Integrative functional genomics of hepatitis C" exact="virus infection" post="identifies host dependencies in complete viral replication cyclePLoS Pathog.201410e100416310.1371/journal.ppat.100416324852294"/>
 <result pre="Arch. Pharmacol.201638969571210.1007/s00210-016-1252-427146293 79.LiQet al.Integrative functional genomics of hepatitis C virus" exact="infection" post="identifies host dependencies in complete viral replication cyclePLoS Pathog.201410e100416310.1371/journal.ppat.100416324852294"/>
 <result pre="genomics of hepatitis C virus infection identifies host dependencies in" exact="complete" post="viral replication cyclePLoS Pathog.201410e100416310.1371/journal.ppat.100416324852294 80.Gebre, M., Nomburg, J. L."/>
 <result pre="of hepatitis C virus infection identifies host dependencies in complete" exact="viral" post="replication cyclePLoS Pathog.201410e100416310.1371/journal.ppat.100416324852294 80.Gebre, M., Nomburg, J. L. &amp;amp;"/>
 <result pre="genetic analysis of virus-host interactions. Viruses10, 55 (2018). 81.KimJHet al.Acute" exact="eosinophilic pneumonia" post="related to a mesalazine suppositoryAsia Pac. Allergy2013313613910.5415/apallergy.2013.3.2.13623667838 82.GuptaAGulatiSMesalamine induced"/>
 <result pre="analysis of virus-host interactions. Viruses10, 55 (2018). 81.KimJHet al.Acute eosinophilic" exact="pneumonia" post="related to a mesalazine suppositoryAsia Pac. Allergy2013313613910.5415/apallergy.2013.3.2.13623667838 82.GuptaAGulatiSMesalamine induced"/>
 <result pre="pneumonia related to a mesalazine suppositoryAsia Pac. Allergy2013313613910.5415/apallergy.2013.3.2.13623667838 82.GuptaAGulatiSMesalamine induced" exact="eosinophilic" post="pneumoniaRespir. Med. Case Rep.20172111611728458997 83.ChiangCWet al.Translational high-dimensional drug interaction"/>
 <result pre="targets and their ligandsNucleic Acids Res.201442D1098D110610.1093/nar/gkt114324234439 91.ApweilerRet al.UniProt: the Universal" exact="Protein" post="knowledgebaseNucleic Acids Res.200432D115D11910.1093/nar/gkh13114681372 92.CoordinatorsNRDatabase resources of the National Center"/>
 <result pre="al.Expression profile of immune response genes in patients with severe" exact="acute" post="respiratory syndromeBMC Immunol.20056210.1186/1471-2172-6-215655079 95.JossetLet al.Cell host response to infection"/>
 <result pre="profile of immune response genes in patients with severe acute" exact="respiratory" post="syndromeBMC Immunol.20056210.1186/1471-2172-6-215655079 95.JossetLet al.Cell host response to infection with"/>
 <result pre="severe acute respiratory syndromeBMC Immunol.20056210.1186/1471-2172-6-215655079 95.JossetLet al.Cell host response to" exact="infection" post="with novel human coronavirus EMC predicts potential antivirals and"/>
</results>
